http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Worksport Ltd. Retains Digital BD to Investigate Short Selling Activity; CEO Reaffirms Confidence with Personal Share Purchase at 44% Premium to Market
-
Greater Miami Convention & Visitors Bureau celebrates 10 years of Art of Black Miami
-
Prestigious Cancer Center Institut Curie Introduces Ibex Medical Analytics’ AI Tools for Cancer Diagnostics
-
NV5 Global (NVEE) Awarded $14 Million in Southern California Municipal Infrastructure Contracts
-
Veradigm Launches an Ambient Scribe Advancement to Ease the Healthcare Administrative Burden
-
Mawson Infrastructure Group Inc. to Ring the Closing Bell at NASDAQ
-
Fraser Institute News Release: Education spending increased in BC since 2012/13 to $14,767 per student, but academic performance substantially declined over same period
-
Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212
-
NV5 Awarded $14 Million in Southern California Municipal Infrastructure Contracts
-
CARB-X Awards Additional Funding to Debiopharm for Continued Development of Early-Stage Antibiotic Targeting Drug-Resistant N. Gonorrhoeae Infections
-
New Consumer Bank Data Finds 69% of Consumers Don't Believe Credit System Is Fair
-
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference
-
Asset Entities Signs Agreement with Netflix Star Jas Leverette to Build Digital Dog Training Community
-
As National Sales of E-Cigarettes Climb, Report Shows that State Restrictions on Flavored Products Are Critical to Protect Young People
-
Dalrada Financial Corporation establishes Deposition Technology Inc. U.S. Presence with new Portland Facility
-
INSIGHTEC SECURES FDA APPROVAL AND CE MARKING FOR EXABLATE® PRIME ON PHILIPS MR SYSTEMS
-
Deloitte Recognizes Cognosos as a Fastest-Growing Company in North America
-
NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)
-
WNS Recognized as a Leader in Supply Chain by ISG
-
Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference
-
Versa Introduces Cloud Firewall on AWS Marketplace
-
Operation HOPE Receives $500,000 Grant from Visa Foundation
-
Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
-
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference
-
Bombardier’s Global 7500 Business Jet Soars to New Heights, Continues Record-Setting Pace with 75 Speed Records
-
Trevi Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference
-
nuEra Cannabis Announces Epic Holiday Specials Kicking Off on "Green Wednesday"
-
Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
-
Novocure (NVCR): FDA Approves Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
-
Jasmine Panayotov, Managing Partner of Proceed Innovative, Wins 2024 Laurie Stone Woman of the Year Award from Schaumburg Business Association
-
Prem Rawat Amplifies Peace Education Initiatives in Madagascar
-
FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
-
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit
-
BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board
-
Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
-
Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
-
Mega Matrix Corp (MPU) Signs MOU with 9Yards Cinema Production to Establish A $100m Investment Fund for Global Short Drama and Pan-Entertainment Sector
-
PAR Technology (PAR) Announces Agreements to Exchange $100 Million of its 2.875% Convertible Senior Notes Due 2026 for Shares of its Common Stock
-
Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities
-
PAR Technology Corporation Announces Agreements to Exchange $100 Million of its 2.875% Convertible Senior Notes Due 2026 for Shares of its Common Stock
-
BioLineRx (BLRX) and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA
-
Laurie Sewell Inducted as President of ISSA, Marking a Milestone in the Organization's 100-Year Legacy
-
BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd.
-
Vext Reports Solid Financial Results for Q3 2024
-
Discover the AQUA (Aquarius) Listing on XT Exchange
-
Biz2Credit’s 2024 Top Small Business Industry Study Finds Manufacturing Leads Other Sectors in Most Financial Measures
-
X's former top policy chief takes job with Elon Musk rival, Sam Altman
-
Discover the ALASKA ($ALASKA) Listing on XT Exchange
-
Vaccinated and Loved: Petco Love Distributes 3 Millionth Free Pet Vaccine
-
Discover the LEMX (Lemon) Listing on XT Exchange


